Market Overview :
The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a CAGR of 7.81% during 2022-2027.
Oncology is a branch of medicine that studies, diagnoses, and treats cancer using various methods such as biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), and positron emission tomography (PET) scanning. On the other hand, oncology based in-vivo CRO refers to the method of treating cancer using contract research organization services. These services conduct research with living organisms such as animals, plants, or whole cells for pharmaceutical, biotechnology, and medical device industries on a contractual basis. In recent years, there has been an escalating demand for oncology based in-vivo CRO due to the development of several investigational compounds for treating cancer.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/oncology-based-in-vivo-cro-market/requestsample
Oncology Based In-Vivo CRO Market Trends and Drivers:
The market is primarily driven by the growing prevalence of cancer across the globe. In addition, the introduction of advanced genetic engineering that helps manipulate deoxyribonucleic acid (DNA) and alter the characteristics of various organisms represents another major growth-inducing factor.
Besides this, contract research organizations (CROs) are conducting extensive research and development (R&D) activities to gain expertise in cancer treatment. They are also offering cost-effective services that are more economical than in-house study. This, coupled with the rising adoption of telehealth and virtual clinical trials in the healthcare industry to ensure the safety of cancer patients, is creating a positive market outlook across the globe.
Moreover, the expanding healthcare industry and the increasing investments by the governments of numerous countries to conduct clinical trials and research activities are also contributing to the market growth.
|Oncology Based In-Vivo CRO Market Report Scope|
|Market size value in 2021||US$ 1.05 Billion|
|Market forecast in 2027||US$ 1.69 Billion|
|Growth Rate||CAGR of 7.81% from 2022 to 2027|
Global Oncology Based In-Vivo CRO Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.
The report has segmented the market on the basis of region, indication, model and application.
Breakup by Indication:
- Blood Cancer
- Solid Tumors
Breakup by Model:
- Patient Derived Xenograft (PDX)
Breakup by Application:
- Rehabilitation Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800